22nd Century Group, Inc. (NASDAQ:NASDAQ:XXII) Q1 2022 Earnings Conference Call May 05, 2022 10:00 AM ET Company Participants Mei Kuo – Director of Communications and Investor Relations Jim.
22nd Century Group, Inc. announced that the U.S. Food and Drug Administration has authorized the marketing of the Companys VLN® King and VLN® Menthol King reduced nicotine content. | December 24, 2021